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The ability to propagate embryonic stem cells (ESCs)
while maintaining their pluripotency is critical if their
potential use in regenerative medicine is to be real-
ized. The mechanisms controlling ESC self-renewal
are under intense investigation, and glycogen syn-
thase kinase 3 (GSK-3) has been implicated in
regulating both self-renewal and differentiation. To
clarify its role in ESCs we have used chemical
genetics. We synthesized a series of bisindolylmalei-
mides, a subset of which inhibit GSK-3 in murine
ESCs and robustly enhance self-renewal in the
presence of leukemia inhibitory factor (LIF) and
serum, but not in the absence of LIF. Importantly,
these molecules appear selective for GSK-3 and do
not perturb other signaling pathways regulating
self-renewal. Our study clarifies the functional impor-
tance of GSK-3 in regulation of ESC self-renewal and
provides tools for investigating its role further.
INTRODUCTION
Embryonic stem cells (ESCs) are derived from the inner cell mass
of preimplantation embryos and can differentiate into all cells
comprising the three germ layers of the developing embryo
(Smith, 2001). This property of pluripotency makes ESCs attrac-
tive for the generation of specific cell types for use in regenera-
tive medicine and drug screening and as amodel system of early
development. In order to harness their potential, the molecular
mechanisms regulating ESC self-renewal need to be understood
such that pluripotency can be maintained during expansion. In
the ESC context, self-renewal is essentially proliferation accom-
panied by the suppression of differentiation and can be defined
as the symmetrical division of ESCs to produce two identical
undifferentiated daughters.
A network of extrinsic factors, signaling pathways, and tran-
scriptional regulators is involved in regulation of ESC self-
renewal, underpining maintenance of pluripotency (Boiani and
Schoeler, 2005). The transcription factors Oct4, Sox2, and
Nanog each play a key role in maintenance of ESC pluripotency
(Boiani and Schoeler, 2005; Niwa, 2007). Of the extrinsic factors,Chemistry & Biology 16leukemia inhibitory factor (LIF) is important for maintaining self-
renewal of murine ESCs (mESCs) (Smith et al., 1988; Smith
and Hooper, 1987) via activation of STAT3 (Boeuf et al., 1997;
Matsuda et al., 1999; Niwa et al., 1998; Raz et al., 1999) and
induction of c-Myc (Cartwright et al., 2005). LIF also activates
the Ras/Erk kinase pathway (Burdon et al., 1999; Ernst et al.,
1996), ribosomal S6 kinases (Boeuf et al., 2001), phosphoinosi-
tide 3-kinases (PI3Ks) (Paling et al., 2004), and Src kinases
(Anneren et al., 2004). LIF-induced ERK activation appears to
promote differentiation (Burdon et al., 1999), leading to the
proposal that the balance between STAT3 and ERK signals are
important in determining mESC fate (Burdon et al., 2002). In
the absence of serum or feeder cells, LIF is not sufficient to
maintain mESC self-renewal but, under chemically defined
conditions, bone morphogenetic protein 4 can synergize with
LIF to maintain self-renewal via induction of Id (inhibitor of differ-
entiation) genes (Ying et al., 2003) and inhibition of p38 mitogen-
activated protein kinase (MAPK) signaling (Qi et al., 2004).
Activation ofWnt signaling and subsequent inhibition ofGSK-3
activity has also been implicated in maintaining self-renewal of
ESCs. Sato et al. used the GSK-3 inhibitor 6-bromoindirubin-
3-oxime (BIO; Meijer et al., 2003) as a surrogate activator of
Wnt signaling and reported that BIO enhanced self-renewal of
both mESCs and human ESCs (hESCs), although these effects
were not quantified at a clonal level (Sato et al., 2004). Subse-
quently, it has been reported that conditioned media containing
Wnt3a can support self-renewal of mESCs (Hao et al., 2006;
Ogawa et al., 2006; Singla et al., 2006) and hESCs (Dravid
et al., 2005; Sato et al., 2004). Tcf-3 was recently shown to co-
occupy promoters with Nanog and Oct4, leading to the sugges-
tion that it integrates Wnt signals with the core regulatory factors
in ESCs (Cole et al., 2008). However, Wnt/b-catenin signaling
alone is not sufficient to maintain self-renewal, as Wnt3a alone
stimulates hESC differentiation and does not maintain mESC
pluripotency (Dravid et al., 2005; Ogawa et al., 2006; Singla
et al., 2006). In addition, expression of an activated mutant of
b-catenin does not maintain self-renewal of mESCs, whereas
overexpression can induce neuronal lineage commitment (Otero
et al., 2004). Furthermore,b-catenin nullmESCsmaintain expres-
sion of pluripotency markers (Anton et al., 2007). Intriguingly,
a distinct GSK-3 inhibitor (TWS119) has been reported to induce
neuronal differentiation of embryonal carcinoma cells and ESCs,
as opposed to self-renewal (Ding et al., 2003), seemingly at odds
with a role for GSK-3 in controlling self-renewal and questioning, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 15
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because GSK-3 is involved in many additional signaling
processes (Cohen and Frame, 2001; Doble and Woodgett,
2003). Importantly, the PI3K/Akt pathway regulates GSK-3
activity in response to cytokines, and a role for PI3K/Akt signaling
in regulation of self-renewal of both mESCs (Paling et al., 2004;
Watanabe et al., 2006) and hESCs (Armstrong et al., 2006; Pyle
et al., 2006) has been demonstrated.
Thus, the functional role that GSK-3 plays in ESC biology
remains enigmatic, and we rationalized that an independent
approach to investigating GSK-3 function in ESCs was
warranted. We have shown that the conformation of macrocyclic
bisindolylmaleimides can be a critical factor in their relative
ability to inhibit alternative protein kinases (Bartlett et al.,
2005). From these studies, compound 1iwas found to be a selec-
tive small-molecule ATP-competitive inhibitor of GSK-3b (Bar-
tlett et al., 2005). We have used 1i as a lead molecule and have
synthesized a further panel of ligands, including potent and
selective GSK-3 inhibitors, to investigate the role of GSK-3 in
mESCs. Our results demonstrate that inhibition of GSK-3
robustly enhances mESC self-renewal in the presence of LIF
and serum, but cannot sustain self-renewal in the absence of
LIF. Importantly, our compounds selectively inhibit GSK-3 and
do not affect signaling via Stat3 andMAPKpathways. Our results
highlight a clear functional role for GSK-3 in regulation of ESC
self-renewal.
RESULTS
Compound 1i Is a GSK-3 Inhibitor in ESCs
Previously, we tested a series of novel bisindolylmaleimides for
activity against a panel of 29 protein kinases in an in vitro screen
using ATP concentrations close to the Km value for each
individual kinase (Davies et al., 2000). In this assay, compound
1i in our current scheme (see below) was demonstrated to
have selectivity for GSK-3b (Bartlett et al., 2005). As a starting
point, it was important to demonstrate that 1i could target
GSK-3 in ESCs, so we directly compared the ability of 1i and
BIO to inhibit GSK-3 activity in ESC lysates (Figure 1A). 1i in-
hibited GSK-3 kinase activity with an IC50 of 250 nM but was
less potent than BIO, which had an IC50 of 50 nM. Using re-
combinant GSK-3b protein, we obtained an IC50 value of
20 nM for 1i (see Table 1; at an ATP concentration of 10 mM),
compared to a published IC50 value of 5 nM for BIO (Meijer
et al., 2003), suggesting an approximately 5-fold difference in
the ability of 1i to inhibit GSK-3 activity compared to BIO.
Affinity purification demonstrated an interaction of 1i with
GSK-3 in ESC extracts. KinaseBind g-phosphate-linked ATP
agarose was used as an affinity matrix to enrich ATP-binding
proteins from ESC lysates. As seen in Figure 1B, BIO, 1i,
TWS119, and ATP all eluted GSK-3b from the ATP agarose. In
addition, preincubation of ESC lysates with BIO or 1i, prior to
incubation with the ATP agarose, abolished binding of GSK-3b
but not of the unrelated kinase Erk1 (Figure 1C). These data
confirm that BIO and 1i compete with the ATP binding site of
GSK-3b in ESCs, consistent with previous reports (Bartlett
et al., 2005; Meijer et al., 2003).
1i has previously been shown to be selective for GSK-3b
(Bartlett et al., 2005). To further explore 1i selectivity, we16 Chemistry & Biology 16, 15–27, January 30, 2009 ª2009 Elsevieranalyzed changes in protein phosphorylation and expression
using the Kinex antibody microarray (Kinexus, Vancouver, BC,
Canada), comprising 250 phospho-site and 350 pan-specific
antibodies. Following 1 or 24 hr treatment with 5 mM 1i, phos-
phorylation of very few proteins were significantly altered
compared to controls (see Table S1 available online), indicating
1i does not have significant off-target effects.
Figure 1. Compound 1i Inhibits GSK-3 Activity in ESC Lysates
(A) ESC lysates were incubated with different concentrations of BIO (filled
triangles) or 1i (filled squares) in the presence of [g-32P]ATP and substrate
peptide for 15 min. Data (mean ± SEM) from three to five independent exper-
iments are expressed as percentage of GSK-3 activity in the absence of inhib-
itor (% control). Incomplete inhibition was observed, likely to be related to
nonspecific background, also noted in GSKa/b null ESCs (Doble et al., 2007).
(B) Elution assay: KinaseBind g-linkedATP agarose beadswere incubatedwith
ESC lysates.Asampleof theextractwassaved (unbound), beadswerewashed,
and bound protein was eluted with 50 mM indicated compound (or 10 mMATP).
The eluates were fractionated by SDS-PAGE on the same 10% acrylamide gel
and immunoblotted with anti-GSK-3b antibodies. The space between samples
is due to removal of two intervening lanes not required for the figure.
(C) Competition assay: ESC extracts were preincubated with 5 mM BIO or 1i
prior to incubation with KinaseBind g-linked ATP agarose. Samples of extract
not bound to the agarose were taken (unbound) and the beads were washed.
The agarose was then boiled in sample buffer to extract the bound proteins
(bound). The samples were immunoblotted with anti-GSK-3b antibodies or
anti-Erk antibodies as indicated.Ltd All rights reserved
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Inhibition of GSK-3 with BIO has been reported to enhance self-
renewal ofmouseandhumanESCs (Satoetal., 2004).Conversely,
a structurally distinct GSK-3 inhibitor, TWS119, promotes
neuronal differentiation ofmESCs (Ding et al., 2003).We therefore
determined the ability of 1i, in direct comparison with BIO and
TWS119, to enhance ESC self-renewal using clonal assays (in
the presence of LIF and serum). Five days after plating, colonies
were stained for alkaline phosphatase activity. Alkaline phospha-
tase isexpressedonlybyundifferentiatedESCs, andstainedcolo-
nies fall into two categories: (1) pure ESC colonies, which have
a compact round morphology and stain intensely, indicative of
a highly self-renewing state (Pure), and (2) less compact colonies
with staining concentrated in the colony center (self-renewing).
Treatment with 5 mM 1i, 0.5 mM BIO, or 2 mM TWS119 resulted in
dramatic increases in the number of pure, highly self-renewing
colonies (Figure 2A). However, above 7.5 mM, toxicity to 1i was
observed. Following treatment with 1i, BIO, or TWS119, expres-
sion of pluripotency markers Nanog and Oct4 were maintained,
and in some cases modestly elevated (Figure 2B; Figure S1),
consistent with retention of an undifferentiated phenotype.
GSK-3 plays a pivotal role in the canonical Wnt signaling
pathway, and although involvement of the Wnt pathway in ESC
self-renewal is controversial, measurement of Wnt signaling
provides a convenient means to assess GSK-3 inhibition in
ESCs. In the absence of Wnts, GSK-3 is active and phosphory-
lates b-catenin, targeting it for degradation. In the presence of
Wnts, GSK-3 is inactivated, b-catenin phosphorylation falls
allowing its levels to rise,whereupon it translocates to thenucleus
and activates transcription via TCF/LEF (T cell factor/lymphoid
enhancer-binding factor) transcription factors. We assessed
the ability of 1i, in comparison with BIO and TWS119, to inhibit
GSK-3 activity in intact ESCs by monitoring their ability to cause
a decrease in levels of b-catenin phosphorylation. As seen in
Figure 2C, levels of b-catenin phosphorylation were modestly
reducedwith 5–7.5 mM 1i, whereas only 0.5 mMBIOwas required
toachievea similar decrease. In contrast, evenat 10mM,TWS119
only led to a modest reduction in b-catenin phosphorylation.
To further assess the ability of 1i to inhibit GSK-3 activity within
ESCs, we used the TOPFlash luciferase reporter assay to assess
upregulation of b-catenin-mediated TCF/LEF transcriptional
activity. Treatment with 5 mM 1i resulted in a 5-fold increase in
TCF reporter activity, comparable to the increase observed
following treatment with 0.5 mM BIO (Figure 2D). Thus, at concen-
trations that decrease b-catenin phosphorylation, both BIO and 1i
induce a corresponding 3- to 5-fold increase in TCF activity.
TWS119 at 2 mM, a dose which enhances mESC self-renewal, led
only to a very modest 1.4-fold increase in TCF activity, raising the
question of whether GSK-3 is the primary target for this molecule
in mESCs. Together, these data indicate that 1i and BIO enhance
self-renewalofmESCs in thepresenceof serumandLIF, aproperty
that correlates with their ability to inhibit GSK-3 activity.
Effects of Related Bisindolylmaleimides on ESC
Self-Renewal
To further probe the relationship between GSK-3 and ESC self-
renewal, we synthesized and functionally characterized a series
of 48 additional molecules related to 1i (see Figure 3) including bi-
sindolylmaleimides (1, 2, 3, and 6), 7-azaindolyl indolylmaleimidesChemistry & Biology 16(4 and 7), and bis-7-azaindolylmaleimides (5); these derivatives
were prepared by alkylation of the heterocyclic ring system and/
or deprotection of the imide nitrogen atom (see Supplemental
Experimental Procedures). The conformation of bisindolylmalei-
mide derivatives plays a major role in their ability to inhibit protein
kinases (Bartlett et al., 2005). To vary the torsion angles between
the maleimide and (aza)indolyl ring systems, we prepared a range
of macrocyclic derivatives in which the length of the tether was
varied, and some analogs in which the 2-position of an indole
ringwasmethylated (Bartlett et al., 2005; Kuoet al., 2003). Figure 3
andTable1summarize themolecular structuresof thecompounds
synthesized and the results of functional evaluation. Sixteen of the
derivatives prepared were found to enhance self-renewal, 12 with
potency equal or better than our lead compound 1i.
Most of the compounds that enhanced self-renewal were
macrocyclic analogs in which the (aza)indolyl nitrogen atoms
were linked by a tether (Table 1). Tether length and substitution
significantly affected the ability of compounds to enhance self-
renewal. Changing tether length from 9 methylene groups (as
in 1i) to 8 (1h; Bartlett et al., 2005) or 11 (1k) reduced potency,
whereas decreasing the tether length to 7 (1g) resulted in a
loss of functional activity (Table 1A). However, the bisindolylma-
leimides 1l and 1m, having polyoxygenated tethers (11 and 14
atoms, respectively), were more potent than 1i and robustly
enhanced ESC self-renewal. However, the corresponding
7-azaindolyl indolylmaleimides (4l and 4m) and bis-7-azaindolyl-
maleimide (5m) derivatives were less potent (Table 1B). Interest-
ingly, the 7-azaindolyl indolylmaleimides (4i) and the bis-7-azain-
dolylmaleimides (5i) had similar potencies to the corresponding
bisindolylmaleimides (1i) (Table 1B).
Theaddition of amethyl group to the2-positionof an indole ring
can change the ligand conformation by widening the torsion
angle between that ring and the maleimide. The addition of
a methyl group to one of the indoles of 1l (to generate 2l) slightly
reduced activity, whereas the same modification of 1m (to
generate 2m) resulted in loss of activity (Table 1A). Adding one
or two methyl groups to 1i (to give 2i and 3i) or to 1h (to give 2h
and 3h) resulted in compounds unable to enhance self-renewal.
The bisindolylmaleimide 2c, with one 2-methylindole ring, was
the only untethered compound that enhanced ESC self-renewal.
A series of analogs in which the tether of 1i was substituted
were prepared (Figure 3B; Table 1C). The introduction of
a hydroxyl group on the central methylene of the tether gave
1o, a molecule that robustly enhanced self-renewal with greater
potency than 1i (the hydroxyl groupmay allow 1o to forman addi-
tional H bond with its target). The addition of an allyloxy or but-3-
enyl substituent at various positions gavemolecules that retained
similar properties to 1i (1p and 1r) or were less effective (1q, 1s,
and1t). These analyses enabled us to groupourmolecules based
on their functional activity in ESC self-renewal. We subsequently
performed more detailed analyses to investigate specific dose-
response characteristics and to determine whether the potency
of GSK-3 inhibition correlated with effects on self-renewal.
Potency of GSK-3 Inhibition Correlates with the Ability
to Enhance ESC Self-Renewal in the Presence of LIF
and Serum
In vitro assays, using recombinant GSK-3b, demonstrated that
three molecules, 1l, 1m, and 1o, had IC50 values for inhibition, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 17
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(A) Effects of Bisindolylmaleimides (1, 2, 3, and 6) on Self-Renewala
Compound R1,R2 SRb Toxicityc GSK-3b IC50
d
1a H,H No No (5 mM) ND
1c Me,Me No 2 mM ND
1e SEM,SEMe No No (5 mM) ND
1g (CH2)7 No No (10 mM) ND
1h (CH2)8 10mM (0.35) No (20 mM) 130
1i (CH2)9 5 mM (0.79) 10 mM 20
1k (CH2)11 10 mM (0.80) No (15 mM) ND
1l Ether (short)(CH2CH2O)3(CH2)2 0.5 mM (0.42) 5 mM 3
1m Ether (long)(CH2CH2O)4(CH2)2 0.5 mM (0.25) No (10 mM) 3
2a H,H No No (5 mM) ND
2b Me,H No No (5 mM) ND
2c Me,Me 2 mM (0.40) 10 mM ND
2d SEMe,H No No (5 mM) ND
2e SEM,SEMe No No (5 mM) ND
2f (CH2)6 No No (5 mM) ND
2h (CH2)8 No No (5 mM) ND
2i (CH2)9 No No (5 mM) ND
2j (CH2)10 No No (5 mM) ND
2l Ether (short)(CH2CH2O)3(CH2)2 2 mM (0.81) No (10 mM) ND
2m Ether (long) (CH2CH2O)4(CH2)2 No No (10 mM) ND
3c Me,Me No No (5 mM) ND
3f (CH2)6 No No (10 mM) ND
3g (CH2)7 No No (10 mM) ND
3h (CH2)8 No No (10 mM) ND
3i (CH2)9 No No (10 mM) ND
3j (CH2)10 No No (10 mM) ND
6a H,H No No (5 mM) ND
(B) Effects of 7-Azaindolyl Indolylmaleimides (4 and 7) and Bis-7-Azaindolylmaleimides (5) on Self-Renewala
Compound R1,R2 SRb Toxicityc GSK-3b IC50
d
4a H,H No No (5 mM) ND
4c Me,Me No No (5 mM) ND
4e SEM,SEMe No No (5 mM) ND
4h (CH2)8 5 mM (0.69) No (15 mM) ND
4i (CH2)9 5 mM (0.39) No (10 mM) ND
4j (CH2)10 No No (5 mM) ND
4l Ether (short)(CH2CH2O)3(CH2)2 5 mM (0.20) No (10 mM) 16
4m Ether (long) (CH2CH2O)4(CH2)2 2 mM (0.65) No (10 mM) ND
5c Me,Me No 1 mM ND
5i (CH2)9 5 mM (0.21) No (10 mM) ND
5m Ether (long) (CH2CH2O)4(CH2)2 10 mM (0.22) No (10 mM) 90
7a H,H No No (5 mM) ND
7d H,SEMe No No (5 mM) ND
(C) Effects of Allyl-Substituted Bisindolylmaleimides on Self-Renewala
Compound R3 R4 SRb Toxicityc GSK-3b IC50
d
1n SitBuPh2 H No No (10 mM) ND
1o H H 0.5 mM (0.56) 5 mM 3
1p CH2CH=CH2 H 5 mM (0.63) No (10 mM) 30
8o H CH2Ph No No (5 mM) ND
1q CH2CH=CH2 H 10 mM (0.55) No (15 mM) ND18 Chemistry & Biology 16, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved
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1s CH2OCH2CH=CH2 H No 10 mM ND
1t CH2CH2CH=CH2 H No 10 mM ND
ND, not determined.
a A series of bisindolylmaleimides were tested for their ability to enhance self-renewal of mESCs as described in Experimental Procedures.
b The concentration at which formation of pure, highly self-renewing colonies emerged is given, along with the index of pure self-renewing colonies/
total colonies at that concentration (in parentheses).
c The concentrations at which the compounds induced cell death are reported. Where no cell death was observed, the concentration at which the
compound was tested is indicated.
d IC50 values (in nM) were determined using recombinant protein and performed as part of the kinase profiling service provided by the Division of Signal
Transduction Therapy, School of Life Sciences, University of Dundee to academic groups.
e SEM, CH2O(CH2)2SiMe3.
Table 1. continued
(C) Effects of Allyl-Substituted Bisindolylmaleimides on Self-Renewala
Compound R3 R4 SRb Toxicityc GSK-3b IC50
dof GSK-3b activity of 3 nM (Tables 1A and 1C). As shown in
Figures 4A–4C, each of these molecules enhanced ESC self-
renewal at concentrations of 0.5 mM and above, compared to
5 mM for 1i. This functional activity correlated with their dose-
response characteristics for GSK-3 inhibition, with doses of
0.5 mM inhibiting b-catenin phosphorylation and enhancing
TCF reporter activity 5- to 7-fold (Figures 4A–4C, panels ii and
iii). Furthermore, following treatment with 1l, 1m, and 1o, expres-
sion of Nanog and Oct4 were maintained, consistent with
retention of pluripotency (Figures 4A–4C, panel iv; Figure S1).
Molecules 2l, 4m, and 2c were slightly more potent than 1i,
consistently promoting ESC self-renewal, inhibiting b-catenin
phosphorylation, and enhancing TCF activity robustly at doses
of 2 mM and above (Figures 4D–4F).
We also characterized compounds 1p, 4l, and 5i, which have
potencies comparable to our lead molecule 1i, and compounds
1h and 5m, which were less potent. These compounds
enhanced self-renewal and inhibited b-catenin phosphorylation
at concentrations of 5–10 mM (Figure S2). In vitro kinase assays
demonstrate that thesemolecules are the least effective at inhib-
iting GSK-3b activity (Table 1), with IC50 values ranging from
16 nM (4l) to 130 nM (1h). Compounds that did not enhance
self-renewal also did not inhibit b-catenin phosphorylation (not
shown). We noted some significant differences between our
results and a study by Kuo et al. (2003). This group also synthe-
sized 1l, 1m, 4l, and 5m, and reported IC50 values for GSK-3
inhibition of 22, 26, 17, and 48 nM, respectively (compared to
our values of 3, 3, 16, and 90 nM). Why these are at variance is
unclear. Surprisingly, whereas Kuo et al. report 5m as their
most specific GSK-3 inhibitor, with little or no inhibition of a panel
of 50 kinases, in our hands this molecule is significantly less
potent at enhancing ESC self-renewal than 1l or 1m.
Direct Effects of Bisindolylmaleimides on Other
Signaling Pathways
We wanted to assess the effects that BIO, TWS119, our lead
compound (1i), and our three most potent compounds (1l, 1m,
and 1o) had directly on other signaling pathways involved in
ESC self-renewal. We examined the Stat3 pathway by
measuring phosphorylation of Stat3 at the activating tyrosine
Y705; PI3K/Akt signaling by analyzing effects on phosphoryla-
tion of ribosomal S6 protein at serines 235/236; and MAPKChemistry & Biology 16signaling by analyzing phosphorylation of the TEY motif on
Erk1 and 2. Following 30 min treatment with BIO (Figure 5A) or
TWS119 (Figure 5B), there was a dramatic reduction in Erk1/2
phosphorylation as well as a decrease in Stat3 Y705 phosphor-
ylation that were not observed with our most potent compounds
(Figure 5). A similar reduction in Erk1/2 phosphorylation was
observed following treatment of GSK-3a/b double knockout
(DKO) mESCs with BIO or TWS119 (Figure S3). S6 phosphoryla-
tion was only reduced by high concentrations of BIO and
TWS119. Compounds 2l, 4m, 2c, 1p, 4l, 5i, 1h, and 5m were
also assessed (Figure S4), and only high concentrations of 5i
led to a noticeable reduction of S6 phosphorylation. These
results highlight that our compounds have little detectable effect
on other downstream signaling pathways known to regulate self-
renewal. This is in contrast to BIO and TWS119, which both had
dramatic inhibitory effects on Erk1/2 signaling in wild-type and
GSK-3 DKO ESCs.
Inhibition of GSK-3 in the Absence of LIF Does Not
Sustain ESC Self-Renewal
Given the ability of a series of bisindolylmaleimides that act as
GSK-3 inhibitors to enhance self-renewal in the presence of
LIF and serum, and in view of earlier reports (Sato et al., 2004),
we also tested whether BIO, 1i, 1l, 1m, or 1o could maintain
self-renewal in the absence of LIF. After 5 days under these
conditions, none of the compounds were able to maintain
a robust population of pure compact self-renewing colonies (Fig-
ure 6A, panels i and ii). Alkaline phosphatase staining was only
weakly enhanced in the presence of 0.5 mM BIO, 1i, 1l, 1m, or
1o compared to untreated (Con) cells, whereas doses of 2 mM
1l, 1m, and 1o led to a decline in total colony number. Consistent
with these effects, treatment with these inhibitors in the absence
of LIF was not sufficient to maintain expression of Nanog or Oct4
(see Figure 6A, panel iii).
We set up similar assays to assess self-renewal using
GSK-3a/b DKO ESCs and compared these to conditionally tar-
geted GSK-3a(flx/flx) cells (WT) (Doble et al., 2007). As seen in
Figure 6B, panels i and ii, in the presence of LIF virtually 100%
of the colonies generated by GSK-3 DKO cells were compact
pure, highly self-renewing colonies, very similar to ESCs treated
with our GSK-3 inhibitors. In contrast, in the absence of LIF there
was a dramatic reduction in the number of pure self-renewing, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 19
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GSK-3 Inhibitors Enhance Self-Renewal of ESCscolonies, accompanied by a decline in Nanog and Oct4 expres-
sion (Figure 6B, panel iii). Therefore, it appears that inhibition of
GSK-3 cannot compensate for lack of LIF signaling to promote
robust self-renewal, at least when the cells are plated at clonal
density in the presence of serum.
DISCUSSION
Using a chemical genetics-based approach, we present data
supporting a role for GSK-3 in the regulation of self-renewal of
mESCs. Our data clearly demonstrate that a series of bisindolyl-
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Figure2. Compound1iTreatmentEnhances
Self-Renewal of ESCs and Inhibits GSK-3-
Mediated Signaling
(A) mESCs were cultured in the presence of the
indicated concentrations of compounds for 5
days and colonies were fixed and stained for alka-
line phosphatase activity. The numbers of pure
colonies (Pure), pure plus self-renewing colony
types (Total SR), and total colony number (Total
colonies) are shown. Data represent the mean ±
SEM of three independent experiments (except
7.5 mM 1i). Inset images show a typical self-renew-
ing colony from untreated ESCs (Con) and typical
pure highly self-renewing colonies formed in the
presence of 0.5 mM BIO, 2 mM TWS119, or 5 mM 1i.
The scale bars represent 400 mm.
(B) ESCs were treated with the indicated concen-
trations of BIO, TWS119, or 1i for 48 or 72 hr.
Lysates were prepared and immunoblotting was
carried out to detect expression of Nanog and
Oct4. Blots were reprobed with anti-SHP-2 anti-
bodies to assess loading.
(C) ESCs were treated with BIO, TWS119, or 1i for
30 min. Immunoblotting was performed with an
antibody detecting phosphorylated b-catenin. The
same immunoblot was reprobed for total b-catenin
to assess loading.
(D) TOPFlash luciferase reporter assay of ESCs
treated for 24 hr with the indicated compounds.
Data represent the mean ± SEM of 3–12 indepen-
dent experiments.
maleimides are capable of enhancing
self-renewal in the presence of LIF and
serum, but not in the absence of LIF.
This property correlated strongly with
the potency of GSK-3 inhibition while
effects on other pathways influencing
self-renewal were not observed. A role
for GSK-3 in the regulation of ESC self-
renewal is further supported by the
demonstration that GSK-3a/b null ESCs
exhibit a similar enhancement of self-
renewal.
How GSK-3 functions to control ESC
fate is not understood. GSK-3 has been
reported to be involved in the regulation
of a number of physiological processes
including metabolism, cell survival,
apoptosis, and translational control, with
more than 40 proteins reported to be substrates for GSK-3,
among them metabolic and signaling proteins, structural
proteins, and transcription factors (Jope and Johnson, 2004).
Sato et al. first implicated GSK-3 in regulation of ESC self-
renewal, their interpretation focusing on inhibition of GSK-3 as
a surrogate activator of the Wnt pathway (Sato et al., 2004).
However, inhibition of GSK-3 is likely to impact on numerous
other pathways in ESCs. Of relevance here is the PI3K/Akt
signaling pathway, activation of which by growth factors and
cytokines leads to inhibition of GSK-3 activity, meaning GSK-3
inhibitors mimic activation of one of the PI3K/Akt effector
20 Chemistry & Biology 16, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved
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GSK-3 Inhibitors Enhance Self-Renewal of ESCspathways. Importantly, PI3K/Akt signaling has been shown to
play a role in regulation of both murine (Paling et al., 2004; Wata-
nabe et al., 2006) and human (Armstrong et al., 2006; Pyle et al.,
2006) ESC self-renewal, whereas others have reported that
PI3Ks regulate ESC proliferation (Jirmanova et al., 2002;
Sun et al., 1999; Takahashi et al., 2003). Although inhibition
of PI3Ks increases GSK-3 activity, there is little evidence
that PI3K/Akt signaling regulates GSK-3 localized within the
Figure 3. The Compounds Used in This Study
(A) The R1 and R2 substituents in the compounds are defined by the suffixes: a: R1 = R2 = H; b: R1 =Me; c: R1 = R2 =Me; d: R1 = CH2O(CH2)2SiMe3, R
2 = H; e: R1 =
R2 = CH2O(CH2)2SiMe3; f: R
1,R2 = -(CH2)6-; g: R
1,R2 = -(CH2)7-; h: R
1,R2 = -(CH2)8-; i: R
1,R2 = -(CH2)9-; j: R
1,R2 = -(CH2)10-; k: R
1,R2 = -(CH2)11-; l: R
1,R2 = -(CH2
CH2O)3(CH2)2-; m: R
1,R2 = -(CH2 CH2O)4(CH2)2-. Compounds with the suffixes f–t are macrocyclic analogs.
(B) The macrocyclic ligands with a functionalized tether that were used in this study.
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GSK-3 Inhibitors Enhance Self-Renewal of ESCsb-catenin disruption complex because (1) treatment with the
PI3K inhibitor LY294002 had little effect on b-catenin phosphor-
ylation or levels (Paling et al., 2004), and (2) despite inducing hy-
perphosphorylation of GSK-3 in mESCs, expression of an acti-
vated form of Akt/PKB did not activate Wnt/b-catenin signaling
(Watanabe et al., 2006). Interestingly, from the point of view of
mechanism, we have shown that compound 1m and BIO can
reverse the effects of inhibition of PI3Ks on ESCs. When PI3Ks
are inhibited, ESCs lose pluripotency and differentiate; however,
if GSK-3 is also inhibited, ESC self-renewal is restored (Storm
et al., 2007). This functional effect correlates with prevention of
Nanog downregulation, observed upon treatment with PI3K
inhibitor alone, suggesting that GSK-3 may play an important
role in regulating levels of Nanog, a master regulator of ESC plu-
ripotency (Chambers et al., 2003, 2007; Mitsui et al., 2003).
Recent work, combined with this study, suggests that the
contributionmade by different signaling pathways tomaintaining
ESC self-renewal is dependent upon the extracellular culture
environment. While this manuscript was in the final stages of
preparation, Ying et al. reported that in serum-free chemically
defined media, a combination of inhibition of both Erk1/2
Figure 5. Effect of Selected GSK-3 Inhibi-
tors on Signaling Pathways in ESCs
(A–F) ESCs were treated with the indicated
compounds for 30 min. Immunoblotting was
carried out on cell lysates extracted from the
treatedcells.Theblotswereprobedwithantibodies
detecting phosphorylated forms of Erk1/2, Stat3,
and S6 ribosomal protein. The same immunoblots
in each case were reprobed for the corresponding
total protein to evaluate loading, except for the
pS6 blots, where GAPDH antibodies were used.
MAPK signaling and GSK-3 was suffi-
cient to maintain ESC self-renewal in the
absence of LIF, BMP4, and even Stat3,
whereas inhibition of GSK-3 alone was
not (Ying et al., 2008). They propose
that under these defined conditions,
GSK-3 inhibition is important for viability
by maintaining metabolic activity and
biosynthetic capacity. Our results
demonstrate that in the presence of
serum and LIF, conditions that already
robustly support ESC metabolism and
proliferation, inhibition of GSK-3 further
enhances ESC self-renewal. We
observed similar effects with GSK-3a/
b DKO ESCs, consistent with a previous
report that GSK-3a/b DKO ESCs are
more resistant to differentiation (Doble
et al., 2007). This leads us to propose that in the presence of
serum and LIF, rather than contributing to self-renewal primarily
via maintenance of viability, as suggested by Ying et al., 2008),
GSK-3 is involved in regulating self-renewal via alternate mech-
anisms (see above). Whereas addition of BIO to ESCs in the
absence of LIF was reported to maintain self-renewal (Ogawa
et al., 2006; Sato et al., 2004), our data, using a clonal functional
assay, indicate that under these conditions, inhibition of GSK-3
alone is not sufficient to maintain self-renewal, consistent with
results in serum-free conditions (Ying et al., 2008). Clearly further
detailed studies are required to elucidate the exact mechanisms
of action of GSK-3 in ESCs exposed to different environmental
milieux.
Not only does our study provide robust evidence that GSK-3 is
involved in regulation of ESC self-renewal but it also provides
important insights into the structure–activity relationships of
bisindolylmaleimides as inhibitors of GSK-3. Our previous work
revealed that tether length played a critical role in constraining
the conformation of bisindolylmaleimides, and this, in turn,
controlled selectivity between alternative protein kinases;
specifically, 1iwas preorganized to function as a GSK-3 inhibitorFigure 4. Characterization of Compounds with Higher Potency in Enhancement of Self-Renewal
ESCswere treated with compounds 1l (A), 1m (B), 1o (C), 2l (D), 4m (E), and 2c (F) and their effects on (i) self-renewal; (ii) and (iii) inhibition of GSK-3 activity and (iv)
expression of Nanog and Oct4 were analyzed. (i) Colonies were fixed and stained for alkaline phosphatase activity and numbers of pure (Pure), self-renewing
(Total SR), and total colonies (Total colonies) are shown. (ii) Immunoblotting to detect b-catenin phosphorylation was carried out as described for Figure 2C.
(iii) TOPFlash reporter assays were performed on extracts from ESCs treated with the indicated concentration of compounds for 24 hr (bottom panel). Data repre-
sent the mean ± SEM of three independent experiments. (iv) Immunoblotting to detect Nanog and Oct4 was carried out as described for Figure 2B.Chemistry & Biology 16, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 23
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our three most potent molecules, 1l, 1m, and 1o, are likely to
adopt a ground-state conformation that is similar to that of 1i.
Furthermore, our comparison between reported inhibitors of
GSK-3, namely BIO (Meijer et al., 2003; Sato et al., 2004) and
TWS119 (Ding et al., 2003) and the bisindolylmaleimides charac-
terized here, highlight a number of advantages of our molecules.
Our analyses reveal that in addition to perturbing phosphoryla-
tion of b-catenin, treatment with BIO or TWS119 also reduced
phosphorylation of Erk1 and 2 and Stat3, indicating that addi-
tional kinases may be targeted by these molecules. In contrast,
our most potent compounds, 1l and 1m, have no detectable
Figure 6. Inhibition of GSK-3 Does Not
Sustain ESC Self-Renewal in the Absence
of LIF
ESCs were incubated with the compounds indi-
cated (A) or wild-type (WT) and GSK-3a/b double
knockout (DKO) cells were cultured (B) in the pres-
ence of serum and the presence or absence of LIF
for 5 days, after which colonies were fixed and
stained for alkaline phosphatase activity. (i) Images
show typical colonies formed from untreated
ESCs (Con), and colonies formed in the presence
of the indicated compounds (A) or colonies formed
by WT and DKO ESCs (B) in the presence and
absence of LIF. The scale bars represent
400 mm. (ii) Alkaline phosphatase staining was
quantified and the numbers of pure (Pure), self-
renewing (Total SR), and total colonies (Total colo-
nies) are shown. (iii) Immunoblotting to detect
Nanog and Oct4 was carried out following 3 day
treatments, as described for Figure 2B.
effect on Erk1/2 or Stat3 phosphorylation
and in this respect are cleaner tools with
which to probe GSK-3 function. This is
further supported by the fact that in an
antibody-based screen our lead molecule
1iwas found to have no significant effects
on the phosphorylation of a wide variety
of proteins.
Our main aim in initiating this study was
to clarify the conflicting reports regarding
the role of GSK-3 in regulation of ESC
fate. Whereas TWS119 was reported to
promote neuronal differentiation of EC
and ES cells (Ding et al., 2003), BIO has
been reported to enhance ESC self-
renewal (Sato et al., 2004), promote prolif-
eration of cardiomyocytes (Tseng et al.,
2006), and preserve hemopoietic stem
cell activity (Holmes et al., 2008). ESC
cultures can be amixture of self-renewing
and differentiating cells, so if a signaling
pathway has a role in both undifferenti-
ated and differentiating cells, inhibition
could have opposite effects depending
on the context. Our finding that both
TWS119 and BIO perturb additional path-
ways prompts us to suggest that using only these molecules to
probe GSK-3 action could lead to unreliable results. Given the
recent report that inhibition of Erk-MAPKs and GSK-3 is suffi-
cient to maintain self-renewal in the absence of exogenous
factors (Ying et al., 2008) and our observation that BIO inhibits
both GSK-3 and Erk1/2 signaling, it would be interesting to
determine whether BIO maintains self-renewal in chemically
defined media.
Overall, by using a chemical genetics-based approach, we
have determined that GSK-3 plays an important role in regulating
the ability of mESCs to self-renew. Our data, together with
a recently published study (Ying et al., 2008), indicate that the
24 Chemistry & Biology 16, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved
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ESC culture environment. Further studies are required to delin-
eate the pathways involved in detail.
SIGNIFICANCE
Embryonic stem cells (ESCs) and their differentiated
progeny represent a renewable source of cells that are
considered to be of wide utility in regenerative medicine,
for cell-based therapies and tissue engineering, and as
a source of differentiated cells for drug discovery, toxicity,
and safety testing. However, in order for this potential to
be realized, undifferentiated pluripotent ESCs need to be
faithfully expanded to generate the large number of cells
required for such purposes. To achieve this, it is imperative
that the signals regulating ESC self-renewal, which under-
pins pluripotency, are understood in detail to ensure they
are appropriately recapitulated during cell expansion.
Previous investigations have suggested that inhibition of
glycogen synthase kinase 3 (GSK-3) by small molecules
can either promote ESC self-renewal, in the case of BIO, or
facilitate neuronal differentiation, observed with TWS119.
To interrogate the involvement of GSK-3 in regulation of
ESC fate in detail, we adopted a chemical genetics-based
approach. We demonstrate that in the presence of serum
and LIF, inhibition of GSK-3 by a series of bisindolylmalei-
mides leads to robust enhancement of ESC self-renewal.
The ability of these molecules to enhance ESC self-renewal
is related to their potency of GSK-3 inhibition and, in
contrast to BIO and TWS119, our most potent GSK-3
inhibitors do not have detectable effects on other pathways
regulating self-renewal. This study further implicates GSK-3
in regulating mESC self-renewal and has provided cleaner
tools to probe the function of GSK-3, applicable to many
diverse cellular settings. We propose that by inhibiting
GSK-3 activity, expansion of pluripotent ESCs will be facili-
tated, a significant benefit for applications requiring large
numbers of undifferentiated cells. In future studies it will
be interesting to determine whether GSK-3 plays a similar
role in regulation of cell fate of induced pluripotent stem
cells.
EXPERIMENTAL PROCEDURES
Culture of mESCs
The E14tg2a mESC line (Smith and Hooper, 1987) was cultured in Knock-out
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 103
units/ml murine LIF (ESGRO; Chemicon) as previously described (Paling
et al., 2004). GSK-3 DKOs and GSK-3a(flx/flx) cells (Doble et al., 2007) (a kind
gift from Dr. J.R. Woodgett, Samuel Lunenfeld Research Institute, Toronto,
ON, Canada and Dr. B. Doble, McMaster University, Hamilton, ON, Canada)
were removed from feeders and maintained as described above.
Alkaline Phosphatase Self-Renewal Assay
ESCs were plated at 1500 cells/well of a six-well tray in Glasgow modified
Eagle’s medium (GMEM) containing 10% (v/v) fetal bovine serum and
103 units/ml LIF. Following 4–6 hr, to permit adherence, compounds were
added without media change. After 5 days, ESC colonies were stained to
detect the presence of alkaline phosphatase (Paling et al., 2004). Colony
images were visualized using an Olympus XI51 inverted microscope and
objective lens and captured using an Olympus Camedia C4040 digital camera.Chemistry & Biology 1Short-Term Treatments and Preparation of Cell Lysates
Compounds were added to mESCs cultured in the presence of serum and LIF
at the indicated concentrations for 30 min and lysates were prepared as
previously described (Welham et al., 1994). Protein concentrations were deter-
mined using the Bio-Rad protein assay kit according to the manufacturer’s
directions. For preparation of cell extracts for antibody microarray screening,
1 3 106 ESCs were lysed and protein samples (100 mg) were analyzed by the
Kinex antibody microarray service (KAM-1.1) performed by Kinexus (Vancou-
ver, BC, Canada).
Immunoblotting
Cell lysates (20 mg) were separated by SDS-PAGE and transferred to nitrocel-
lulose as described previously (Welham et al., 1994). Immunoblotting was
carried out using primary antibodies at the following dilutions: 1:1,000 anti-
GSK-3b (Cell Signaling Technology; CST 9315), anti-b-catenin (CST 9562),
anti-Oct4 (Santa Cruz Biotechnology; sc-9801), anti-Nanog (Abcam; Ab-
21603); 1:2000 anti-Erk1 (sc-93), anti-GAPDH (sc-20357); 1:20,000 anti-phos-
pho (Ser33/37/Thr41) b-catenin (CST 9561); 1:1,000 anti-phospho (Thr202/
Tyr204) Erk1/2 (CST 9101), anti-phospho (Tyr705) Stat3 (CST 9131); 1:2,000
anti-phospho (Ser235/236) S6 ribosomal protein (CS 2211). Anti-rabbit anti-
bodies conjugated to horseradish peroxidase (DAKO) were used at 1:10,000
and blots were developed using ECL or ECL Advance according to the manu-
facturer’s directions (GE Healthcare). Blots were stripped and reprobed as
previously described (Welham et al., 1994).
ATP Bead Assay
KinaseBind g-linked ATP agarose beads (Innova Bioscience) were prepared in
wash buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 20 mM MgCl2, 1 mM DTT).
mESC lysate (6 mg/ml) was incubated, with rotation, at 4C with 400 ml beads.
After 3 hr the supernatant was removed (unbound) and the beadswere washed
six times. Beads were divided into seven aliquots, wash buffer was removed,
and 50 ml of the eluting compound (50 mM BIO, 1i, or TWS119, or 10 mM ATP)
was added to the beads. After a 1 hr incubation at 4C, the beadswere pelleted
and the supernatant was removed (eluted protein). Alternatively, mESC lysates
were incubated at 4C for 15 min with 5 mM compound prior to addition of
beads. Following a 3 hr incubation, unbound samples were removed, the
beads were washed in wash buffer containing 5 mM compound, and bound
proteins were released by boiling the beads in 13 sample buffer.
GSK-3 Kinase Assay
GSK-3 specific activity was determined by measuring the transfer of 32P from
[g-32P]ATP to the GSK-3-specific peptide substrate GSM (Millipore; Ryves
et al., 1998). To measure total GSK-3 activity, a 25 ml reaction was used con-
taining 12.5 ml of ESC lysate (1 mg/ml) in the absence or presence of the
indicated concentrations of compounds, 0.5 mg/ml GSM peptide substrate,
50 mM HEPES, 12.5 mM MgCl2, 2 mM DTT, 100 mM ATP, and 2.5 mCi
[g-32P]ATP (10 mCi/ml; 3000 Ci/mmol; GE Healthcare). After 15 min at room
temperature, the assay was terminated by spotting 20 ml onto P81 Whatman
ion-exchange paper, which was washed four times (30 min each) in 0.6%
phosphoric acid and dried, and bound radioactivity was quantified by scintil-
lation counting.
Luciferase Reporter Assay to Measure b-Catenin-Mediated
Transcriptional Activity
mESCs were cotransfected with 2 mg TOPFlash (containing four consensus
TCF binding sites upstream of the c-fosminimal promoter, driving expression
of a firefly luciferase reporter) or FOPFlash (containing four mutant TCF binding
sites) reporter constructs (kindly provided by C. Dani, CNRS, Nice, France) and
40 ng Renilla luciferase control vector phRL-TK (pRL-TK; Promega) using 20 ml
Lipofectamine 2000 (Invitrogen). After 24 hr, transfected cells were replated at
2 3 105 cells in 2 ml GMEM/well of a 12-well tray and treated with compound
as indicated. After a further 24 hr, cell extracts were prepared and firefly and
Renilla luciferase activities were determined using the dual-luciferase reporter
assay system according to the manufacturer’s instructions (Promega).
TOPFlash/FOPFlash firefly luciferase activities were normalized to those of co-
transfected phRL-TK Renilla luciferase activity. Any FOPFlash activity was
subtracted from TOPFlash activity and data were represented as fold increase
above unstimulated control values.6, 15–27, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 25
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